Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2015-02-28
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Decision Aids to Enhance Shared Decision Making for Diabetes
NCT01029288
Diabetes Medication Choice
NCT00388050
Improving Diabetes Care With Patient Decision Aids - A Trial in Community-based Primary Care
NCT00668590
Impact of an Interprofessional Shared Decision-making and Goal-setting Decision Aid for Patients With Diabetes
NCT02379078
Shared Decision Making Between Patients and GPs in the Treatment of Type 2 Diabetes in Primary Care.
NCT02285881
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pharmaceutical care with shared decision making
Use of Diabetes Issue Cards Decision Aids
Diabetes Issue Cards Decision Aids
Usual Pharmaceutical care
Usual Care
Usual Pharmaceutical Care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diabetes Issue Cards Decision Aids
Usual Pharmaceutical Care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with type II diabetes by ICD-9 code for more than one year
* HbA1c of 7%-9.5% within past 6 months
* Prescribed three or less anti-hyperglycemic medications as indicated by the medication list within the medical record
Exclusion Criteria
* Pregnancy
* Appointment with provider within a month
* Appointment with provider within the last month
* Followed by endocrinology
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joseph R. Herges, Pharm.D., R.Ph.
Doctor of Pharmacy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic Kasson
Kasson, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-009665
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.